Inspiring Better Healthcare

Healthcare at Ipsos

We work in partnership with healthcare sector clients, empowering them to align commercial success with what matters most: improving patients’ lives.

	POINT OF VIEW Why oncologists are prescribing GLP-1s Evidence-based understanding of why cancer specialists are embracing – and sometimes avoiding – GLP-1s.
	PRESS RELEASE Two-Thirds of People Living with Obesity Blame Themselves, Despite WHO Classifying Obesity as a Disease Ipsos releases key findings from the syndicated Global Perceptions of Obesity Study, which surveyed 14,500 people in 14 countries, to mark World Obesity Day 2026.
	WEBINAR Advances in Metabolic Therapeutics for Obesity, Diabetes and MASH Watch our cardiometabolic experts guide viewers through the recent transformations in metabolic therapeutics for obesity, diabetes and MASH, and where the field is heading next
	POINT OF VIEW Oncology: The Disease, Dynamics & Challenges of Market Research Our 2026 update outlining the considerations and challenges for professionals who market, or conduct marketing research for, oncology products.
	RESEARCH SOLUTION Ipsos Rx Insight Store Over 80 reports now available across multiple therapy areas and healthcare topics, ensuring access to the most relevant market insights for brand success
	REPORT The GLP-1 Revolution - What's changed in 2025? As part of Ipsos’ Year in Review, Jackie Ilacqua charts the transformative impact of GLP-1s to date – concluding that if 2024 was the year GLP-1 drugs went mainstream, 2025 is the year they matured…